Vancomycin-resistant enterococci colonization-infection model: Parameter impacts and outbreak risks

Journal of Biological Dynamics

Volumn 6, Issue 2, 2012, Pages 645-662

  Yahdi, Mohammed ^a   Abdelmageed, Sara ^a   Lowden, Jon ^b   Tannenbaum, Lloyd ^a  

^a URSINUS COLLEGE   (United States)

^b CALIFORNIA UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

basic reproduction number; drug resistance; infection control; parameter impact; vancomycin resistant enterococci

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BASIC REPRODUCTION NUMBER; BIOLOGICAL MODEL; COMPUTER SIMULATION; DRUG EFFECT; ENTEROCOCCUS; EPIDEMIC; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTENSIVE CARE UNIT; MICROBIOLOGY; RISK FACTOR; STATISTICS;

BACTERIAL INFECTIONS; BASIC REPRODUCTION NUMBER; COLONY COUNT, MICROBIAL; COMPUTER SIMULATION; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; HUMANS; INTENSIVE CARE UNITS; MODELS, BIOLOGICAL; RISK FACTORS; VANCOMYCIN;

EID: 84868326336     PISSN: 17513758     EISSN: 17513766     Source Type: Journal    
DOI: 10.1080/17513758.2012.670733     Document Type: Article

References (49)

1. Bakir, M., Bova, J. L., Newell, K. A., Millis, J. M., Buell, J. F and Arnow, P. M. 2001. Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation, 72: 1032-1037.
2. Bhorade, S. M., Christenson, J., Pohlman, A. S., Arnow, P. M. and Hall, J. B. 1999. The incidence of and clinical variables associated with vancomycin-resistant enterococcus colonization in mechanically ventilated patients. Chest, 115: 1085-1091.
3. Bonten, M. J., Slaughter, S., Ambergen, A. W., Hayden, M. K., van Voorhis, J., Nathan, C. and Weinstein, R. A. 1998. The role of 'colonization pressure' in the spread of vancomycin-resistant enterococci: An important infection control variable. Arch. Intern. Med., 158: 1127-1132.
4. Bonten, M., Austin, D. and Lipsitch, M. 2001.Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control. Clin. Infect. Dis., 33: 1739-1746.
5. Boyce, J., Opal, S., Chow, J., Zervor, M., Potter-Bynoe, G., Sherman, C., Romulo, R., Fortna, S. and Merdeiros, A. 1994. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol., 32(5): 1148-53.
6. Brennen, C., Wagener, M. and Muder, R. 1998. Vancomycin-resistant Enterococcus faecium in a long-term care facility. J. Am. Geriatr. Soc., 46: 157-160.
7. Cacuci, D. G. 2003. Sensitivity and Uncertainty Analysis. Theory, Vol. 1., London: Chapman & Hall.
8. Carmeli, Y., Samore, M. and Huskins, C. 1999. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: A meta-analysis. Arch. Intern. Med., 159: 2461-2468.
9. Carmeli, Y., Eliopoulos, G., Mozaffari, E. and Samore, M. 2002. Health and economic outcomes of vancomycin-resistant enterococci. Arch. Intern. Med., 162: 2223-2228.
10. Choi, S., Lee, S., Kim, T., Chung, J., Choo, E., Kwak, Y., Kim, M., Kim, Y., Woo, J., Ryu, J. and Kim, N. 2003. Clinical features and outcomes of Bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: Analysis of 56 cases. Clin. Infect. Dis., 38: 53-61.
11. D'Agata, E., Webb, G. and Horn, M. 2005. A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycin-resistant enterococci. J. Infect. Dis., 192: 2004-2011.
12. Drews, S., Johnson, G., Gharabaghi, F., Roscoe, M., Matlow, A., Tellier, R. and Richardson, S. 2006. A 24-hour screening protocol for identification of vancomycin-resistant enterococcus faecium. J. Clin. Microbiol., 44(4): 1578-1580.
13. Edmond, M. B., Ober, J. F., Dawson, J. D., Weinbaum, D. L. and Wenzel, R. P. 1996. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin. Infect. Dis., 23: 1234-1239.
14. Freitas, A., Novais, C., Ruiz-Garbajosa, C., Coque, T. and Peixe, L. 2009. Clonal expansion within clonal complex 2 and spread of vancomycin-resistant plasmids among different genetic lineages of Enterococcus faecalis from Portugal. J. Antimicrob. Chemother., 63: 1104-1111.
15. Campos Furtado, G. H., Mendes, R. E., Campos Pignatari, A. C., Wey, S. B. and Servolo Medeiros, E. A. 2006. Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: An analysis of two case-control studies. Am. J. Infect. Control, 34: 447-451.
16. Gould, D., Drey, N., Moralejo, D., Grimshaw, J. and Chudleigh, J. 2008. Interventions to improve hand hygiene compliance in patient care. J. Hosp. Infect., 68: 193-202.
17. Grievank, A. 2000. Evaluating Derivatives, Principles and Techniques of Algorithmic Differentiation, Philadelphia: SIAM.
18. Huang, S., Datta, R. and Platt, R. 2006. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch. Intern. Med., 166(18): 1945-1951.
19. Kapur, D., Dorsky, D., Feingold, J. M., Bona, R. D., Edwards, R. L., Aslanzadeh, J., Tutschka, P. J. and Bilgrami, S. 2000. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant., 25: 147-152.
20. Knaus, W., Wagner, D., Zimmerman, J. and Draper, E. 1993. Variations in mortality and length of stay in intensive care units. Ann. Intern. Med, 118(10): 753-761.
21. Linden, P. K., Pasculle, A. W., Manez, R., Kramer, D. J., Fung, J. J., Pinna, A. D. and Kusne, S. 1996. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin. Infect. Dis., 22: 663-670.
22. Lipsitch, M., Bergstrom, C. and Levin, B. 2000. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc. Natl. Acad. Sci., 97(4): 1938-1943.
23. Lipsitch, M. and Bergstrom, C. 2002. Modeling of antibiotic resistance in the ICU-US slant. Res. Works Washington,: 1-16.
24. Lucas, G. M., Lechtzin, N., Puryear, D. W., Yau, L. L., Flexner, C. W. and Moore, R. D. 1998. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin. Infect. Dis., 26: 1127-1133.
25. MaineHealth Infection Prevention and Control Consortium. 2007. Antibiotic Resistance Bacteria-VRE. Healthcare worker information packet,: 1-2. available at http://www.mmc.org.
26. Mainous, M., Lipsett, P. and O'Brien, M. 1997. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality?. Johns Hopkins SICU Study Group. Arch. Surg., 132: 76-81.
27. Matar, M. J., Tarrand, J., Raad, I. and Rolston, K. V.I. 2006. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am. J. Infect. Control, 34: 534-536.
28. McDonald, L., Kuehnert, M., Tenover, F. and Jarvis, W. 1997. Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg. Infect. Dis., 3(3): 1-10.
29. McNeil, S., Malani, P., Chenoweth, C., Fontana, R. J., Magee, J. C., Punch, J. D., Mackin, M. L. and Kauffman, C. A. 2006. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: A prospective surveillance study. Clin. Infect. Dis., 42: 195-203.
30. Montecalvo, M. A., Horowitz, H., Gedris, C., Carbonaro, C., Tenover, F. C., Issah, A., Cook, P. and Wormser, G. P. 1994. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob. Agents Chemother., 38: 1363-1367.
31. Muto, C. A., Jernigan, J. A., Ostrowsky, B. E., Richet, H. M., Jarvis, W. R., Boyce, J. M. and Farr, B. M. 2003. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect. Control Hosp. Epidemiol., 24: 639-641.
32. Olivier, C., Blake, R., Steed, L. and Salgado, C. 2008. Risk of vancomycin-resistant enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect. control hosp. epidemiol., 29(5): 404-409.
33. Patel, R., Allen, S. L., Manahan, J. M., Wright, A. J., Krom, R. A., Wiesner, R. H., Persing, D. H., Cockerill, F. R. and Thompson, R. L. 2001. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl., 7: 27-31.
34. Ramadhan, A. and Hegedus, E. 2005. Survivability of vancomycin resistant enterococci and fitness cost of vancomycin resistance acquisition. J. Clin. Pathol., 58(7): 744-746.
35. Reid, K., Cockerill, F. and Patel, R. 2001. Clinical and epidemiological features of Enterococcus casseliflavus/flavescens and Enterococcus gallinarum Bacteremia: A report of 20 cases. Clin. Infect. Dis., 32: 1540-1546.
36. Roche Diagnostics Corporation. 2009. Clinical reviews: Vancomycin-resistant enterococci (VRE). Med. Sci. Aff.,: 1-6.
37. Salgado, C. and Farr, B. 2003. Outcomes associated with vancomycin-resistant enterococci: A meta-analysis. Infect. Control Hosp. Epidemiol., 24(9): 690-698.
38. Shay, D. K., Maloney, S. A., Montecalvo, M., Banerjee, S., Wormser, G. P., Arduino, M. J., Bland, L. A. and Jarvis, W. R. 1995. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J. Infect. Dis., 172: 993-1000.
39. J.D. Siegel, E. Rhinehart, M. Jackson, L. Chiarello, and the Healthcare Infection Control Practices Advisory Committee, Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006. Center for Disease Control and Prevention. Available 31 October 2007 at http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf.
40. Sood, S., Malhorta, M., Das, B. and Kapil, A. 2008. Enterococcal infections & antimicrobial resistance. Indian J. Med. Resist., 128: 111-120.
41. Stosor, V., Peterson, L. R., Postelnick, M. and Noskin, G. A. 1998. Enterococcus faecium bacteremia: Does vancomycin resistance make a difference?. Arch. Intern. Med., 158: 522-527.
42. Tacconelli, E. and Cataldo, M. 2008. Vancomycin-resistant enterococci (VRE): Transmission and control. Int. J. Antimicrob. Agents, 31: 99-106.
43. Turanyi, T. and Rabitz, H. 2000. "Local methods". In Sensitivity Analysis, Wiley Series in Probability and Statistics Edited by: Saltelli, A., Chan, K. and Scott, E. M. New York
44. Van den Driessche, P. and Watmough, J. 2002. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci., 180: 29-48.
45. Varma, A., Morbidelli, M. and Wu, H. 1999. Parametric Sensitivity in Chemical Systems, Cambridge: Cambridge University Press.
46. Yahdi, M. and Much, K. 2009. Mathematical modeling and sensitivity analysis of antibiotic resistance, abstracts of the MAPS 2009 meeting. ASPET J., 51(4): 119-131.
47. Zaas, A. K., Song, X., Tucker, P. and Perl, T. M. 2002. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin. Infect. Dis., 35: 1139-1146.
48. Zirakzadeh, A. and Patel, R. 2006. Vancomycin-resistant enterococci: Colonization, infection, detection, and treatment. Mayo Clin. Proc., 81: 529-536.
49. (August 22, 2008). About Antibiotic Resistance. Department of Health and Human Services Centers for Disease Control and Prevention. Available at http://www.cdc.gov/drugresistance/community/anitbiotic-resistance-faqs.htm6 (accessed 22 August 2008).